136 related articles for article (PubMed ID: 1448309)
1. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer.
Katz JA; Mustafa MM; Bash RO; Cash JV; Buchanan GR
Pediatr Infect Dis J; 1992 Sep; 11(9):708-12. PubMed ID: 1448309
[TBL] [Abstract][Full Text] [Related]
2. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
4. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
Abrahamsson J; Påhlman M; Mellander L
Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.
Stryjewski GR; Nylen ES; Bell MJ; Snider RH; Becker KL; Wu A; Lawlor C; Dalton H
Pediatr Crit Care Med; 2005 Mar; 6(2):129-35. PubMed ID: 15730597
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
Santolaya ME; Cofre J; Beresi V
Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
[TBL] [Abstract][Full Text] [Related]
9. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer.
Urbonas V; Eidukaitė A; Tamulienė I
J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386
[TBL] [Abstract][Full Text] [Related]
11. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.
Vettenranta K; Hovi L; Mäkipernaa A; Jalanko H; Saarinen-Pihkala UM
Acta Paediatr; 2002; 91(8):915-9. PubMed ID: 12222715
[TBL] [Abstract][Full Text] [Related]
13. Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.
Diepold M; Noellke P; Duffner U; Kontny U; Berner R
BMC Infect Dis; 2008 Mar; 8():28. PubMed ID: 18321393
[TBL] [Abstract][Full Text] [Related]
14. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
15. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
16. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
17. Serial serum C-reactive protein levels in the diagnosis of neonatal infection.
Benitz WE; Han MY; Madan A; Ramachandra P
Pediatrics; 1998 Oct; 102(4):E41. PubMed ID: 9755278
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
19. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.
Heney D; Lewis IJ; Evans SW; Banks R; Bailey CC; Whicher JT
J Infect Dis; 1992 May; 165(5):886-90. PubMed ID: 1569338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
